Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Oct 31, 2025 | (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q4)Apr 30, 2025 | (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -58.41%-1.19M | 12.32%-827.32K | -20.58%-4.38M | -9.39%-1.03M | -63.17%-1.65M | -11.40%-750.58K | 5.78%-943.61K | 43.16%-3.63M | -27.79%-944.79K | 39.05%-1.01M |
| Net income from continuing operations | -114.52%-4.97M | -16.64%-1.01M | -54.75%-5.73M | 4.72%-1.02M | -42.87%-1.54M | -226.92%-2.32M | -1.19%-865.32K | 41.42%-3.71M | -34.25%-1.07M | 3.49%-1.08M |
| Operating gains losses | -34.27%5.37K | -347.72%-1.28K | 685.74%9.65K | 294.59%8.78K | -209.00%-7.01K | 247.97%8.17K | -114.60%-285 | 92.33%-1.65K | 49.79%-4.51K | 253.99%6.43K |
| Asset impairment expenditure | ---- | ---- | --193.38K | --0 | --0 | ---- | ---- | --0 | --0 | --0 |
| Remuneration paid in stock | ---- | ---- | 10,657.65%1.35M | --0 | --18.58K | ---- | ---- | -87.31%12.53K | --12.53K | --0 |
| Other non cashItems | --0 | --33.32K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 66.37%59.12K | 292.22%149.94K | -422.79%-197.62K | -122.53%-25.71K | -334.91%-129.43K | -11.94%35.53K | 47.42%-78.01K | 142.60%61.22K | 77.36%114.12K | 110.11%55.1K |
| -Change in receivables | 892.26%15.66K | -33,840.30%-22.61K | -2,715.55%-54.67K | 518.70%6.29K | -689.85%-59.04K | -218.74%-1.98K | -99.03%67 | -75.03%2.09K | 115.07%1.02K | -258.64%-7.48K |
| -Change in prepaid assets | -227.09%-68.32K | 137.04%9.92K | -245.39%-80.02K | -130.83%-25.8K | -56.37%-81.19K | -4.44%53.76K | 18.80%-26.79K | -48.90%55.03K | 292.30%83.69K | -5,869.33%-51.92K |
| -Change in payables and accrued expense | 787.89%111.78K | 417.09%162.62K | -1,636.12%-62.94K | -121.07%-6.2K | -90.57%10.8K | 7.53%-16.25K | 58.05%-51.29K | 101.58%4.1K | -74.33%29.42K | 120.80%114.5K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -58.41%-1.19M | 12.32%-827.32K | -20.58%-4.38M | -9.39%-1.03M | -63.17%-1.65M | -11.40%-750.58K | 5.78%-943.61K | 43.16%-3.63M | -27.79%-944.79K | 39.05%-1.01M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -988.13%-1.58M | -99.91%-82.13K | 30.87%-212.25K | 12.10%-25.89K | 0 | 19.83%-145.27K | 27.06%-41.09K | -22.24%-307.04K | 35.49%-29.46K | -60.71%-40.07K |
| Net PPE purchase and sale | -988.13%-1.58M | -99.91%-82.13K | 27.73%-221.89K | -20.66%-35.54K | --0 | 19.83%-145.27K | 27.06%-41.09K | -22.24%-307.04K | 35.49%-29.46K | -60.71%-40.07K |
| Net other investing changes | ---- | ---- | --9.65K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -988.13%-1.58M | -99.91%-82.13K | 30.87%-212.25K | 12.10%-25.89K | --0 | 19.83%-145.27K | 27.06%-41.09K | -22.24%-307.04K | 35.49%-29.46K | -60.71%-40.07K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -12.99%447.74K | 330.72%13.81M | 7.32M | 3.5M | 102.45K | 514.6K | 3.21M | 0 | 0 | 0 |
| Net common stock issuance | -74.46%470.29K | 636.21%15M | --7.64M | --3.7M | --56K | --1.84M | --2.04M | --0 | --0 | --0 |
| Net other financing activities | 98.30%-22.55K | -201.93%-1.19M | ---316.89K | ---204.93K | --46.45K | ---1.33M | --1.17M | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -12.99%447.74K | 330.72%13.81M | --7.32M | --3.5M | --102.45K | --514.6K | --3.21M | --0 | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 454.19%16.36M | 373.47%3.46M | -84.36%730.46K | -40.16%1.02M | -6.83%2.57M | -18.37%2.95M | -84.36%730.46K | -58.67%4.67M | -68.73%1.7M | -61.31%2.76M |
| Current changes in cash | -509.03%-2.32M | 480.72%12.9M | 169.23%2.73M | 350.39%2.44M | -47.24%-1.55M | 55.41%-381.25K | 309.99%2.22M | 40.69%-3.94M | -24.11%-974.25K | 37.58%-1.05M |
| Effect of exchange rate changes | -3,094.07%-7.07K | 26,150.00%525 | --0 | -286.83%-695 | 139.60%457 | 111.10%236 | -99.94%2 | -97.41%332 | -93.36%372 | -115.44%-1.15K |
| End cash Position | 445.74%14.03M | 454.19%16.36M | 373.47%3.46M | 373.47%3.46M | -40.16%1.02M | -6.83%2.57M | -18.37%2.95M | -84.36%730.46K | -84.36%730.46K | -68.73%1.7M |
| Free cash from | -209.17%-2.77M | 7.64%-909.45K | -16.82%-4.6M | -9.73%-1.07M | -56.97%-1.65M | -4.78%-895.85K | 6.91%-984.69K | 40.69%-3.94M | -24.11%-974.25K | 37.58%-1.05M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.